[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account

Clinical Expertise

  • Acute Myeloid Leukemia

About

Dr Saar Gill is an associate professor of medicine in the division of hematology-oncology at the University of Pennsylvania. Dr Gill trained in clinical hematology in his native Australia, followed by a post-doctoral fellowship at Stanford University. Since 2011 he has been working on developing genetically engineered immune cells for the treatment of cancer. Dr Gill is a physician-scientist who places a strong emphasis on translational research, and concepts developed in his laboratory have already led to several clinical trials for the treatment of hematologic malignancies. Dr. Gill co-founded Carisma Therapeutics with his first graduate student, Michael Klichinsky, and recently co-founded Interius Biotherapeutics. He is a member of the American Society of Hematology Scientific Sub-Committee on Myeloid Neoplasia, elected to the American Society of Clinical Investigation, a past chair of the Cancer and Gene Therapy committee of the American Society of Gene & Cell Therapy, and a co-chair of the American Society of Transplantation and Cell Therapy’s Women, Under-represented Minorities and LGBTQ Special Interest Group.

Location

University Of Pennsylvania Abramson Cancer Center: Perelman Center for Advanced Medicine, 3400 Civic Center Blvd, Philadelphia, PA 19104, USA

newsletter icon

Get the latest thought leadership on your Blood Cancer delivered straight to your inbox

Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.